]>
IRCT20111121008146N44 IRCT 2023-06-20 Shahid Beheshti University of Medical Sciences Investigating the effects of intravenous laser on creatinine and GFR in chronic kidney patients Investigating the effects of intravenous laser on creatinine and GFR in chronic kidney patients 2023-06-22 anticipated 50 Complete https://irct.ir/trial/70231 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: All patients are divided into case and control groups based on the table of random numbers with a ratio of 1:1. The assigned group is placed in dark envelopes one after the other. This envelope will be opened by the treating doctor only after the initial evaluation of each person, and neither the patient nor the clinical evaluator will know about his treatment group. Etiology factors include sepsis, rhabdomyolysis and drugs in both match groups, Blinding description: In the control group, the Sham laser is used by the operator And the reashercher and the patient are unaware of the type of group. 3 chronic kidney disease. Intervention 1: Intervention group: continuous or pulsed intravenous or near-infrared laser (600-1100 nm) with a power of 2 MW for 30 minutes, which is irradiated into the blood through a sterile disposable catheter. Two millimeters of optical fiber are inserted into the vein and distributed in the blood circulation. Intravenous laser is performed every other day for 7 sessions. Intervention 2: Control group: Sham laser. No - There is not a plan to make this available Justification or reason for not sharing IPD is The publication is in the form of an article and it is not necessary to provide data in the article
public Mohammadreza Razzaghi
Shohada Tajrish Hospital, Shahrdari st, Tajrish sq, Tehran
Tehran Iran (Islamic Republic of) 1989934148 +98 21 2271 8021 m-razaghi@sbmu.ac.ir Shahid Beheshti University of Medical Sciences scientific Esmat Ghanei
Shohada Tajrish Hospital, Shahrdari st, Tajrish sq, Tehran
Tehran Iran (Islamic Republic of) 1989934148 +98 21 2271 8021 dr_e_ghanei@yahoo.com Shahid Beheshti University of Medical Sciences Iran (Islamic Republic of) Patients with a chronic kidney disease called CKD and with GFR below 20 who have not been treated with dialysis. no limit no limit Both Patients with pre-renal and post-renal acute kidney disease, patients with glomerulonephritis and patients who need immunosuppressive drugs, including lupus, patients who have taken omega-3 and corticosteroids in the last month, pregnant patients, sensitive to light and suffering from malignancy N18 Chronic kidney disease (CKD) Treatment - Devices Treatment - Other Intervention group: continuous or pulsed intravenous or near-infrared laser (600-1100 nm) with a power of 2 MW for 30 minutes, which is irradiated into the blood through a sterile disposable catheter. Two millimeters of optical fiber are inserted into the vein and distributed in the blood circulation. Intravenous laser is performed every other day for 7 sessions. Control group: Sham laser Serum Cr. Timepoint: before and after treatment. Method of measurement: blood samples. 24 hours GFR. Timepoint: before and after treatment. Method of measurement: 24 hours urine analysis. Urine output. Timepoint: before and after treatment. Method of measurement: urine analysis. Blood urea nitrogen. Timepoint: before and after treatment. Method of measurement: blood sample. Shahid Beheshti University of Medical Sciences Approved 2023-03-01 Ethics committee in research of laser application in medical sciences research center Shohadaye Tajrish hospital, shahdari street, Tajrish distinct Tehran Tehran Iran (Islamic Republic of)